The effect of melatonin supplementation on lead, calcium and magnesium distribution in the tissues of lead-exposed rats

• Autorzy: Baranowska-Bosiacka I , Gutowska I. , Marchlewicz M. , Nocen I. , Czuprynska K. , Olszewska M. , Skotnicka E. , Jach M. , Wiszniewska B. , Chlubek D.
• Języki publikacji: EN

Abstrakty

EN

The aim of this study was to determine whether oral supplementation of melatonin (M), a known antioxidant, free radical scavenger and metal chelator, influences lead (Pb), calcium (Ca) and magnesium (Mg) distribution in the blood, bones and teeth of rats exposed chronically to lead. The studies were carried out on male Wistar rats which, from their birth until reaching sexual maturity (for 3 months), drank water containing 1% lead (II) acetate and/or received melatonin in feed (1mg/ kg body wt.) over a 3-month period. Concentrations of Pb, Ca and Mg were analyzed by atomic absorption spectrometry (AAS). Exposure to Pb and Pb plus M resulted in a significant increase in the Pb concentration in the whole blood (but below the threshold level) and bones in both groups. In rats chronically exposed to lead during their fast development (from birth until reaching sexual maturity), melatonin supplementation did not cause a significant decrease in Pb concentration in whole blood and bones. No changes were observed in blood plasma Ca and Mg concentrations in rats exposed to lead and treated with melatonin. However, their bones were observed to have a lower Ca concentration and higher Mg concentration, and their teeth higher Ca and Mg concentrations.

• Wydawca: -
• Czasopismo: Polish Journal of Environmental Studies
• Rocznik: 2008
• Tom: 17
• Numer: 2
• Opis fizyczny: p.181-188,fig.,ref.

Twórcy

autor

Baranowska-Bosiacka I

• Pomeranian Medical University, Powst.Wlkp. 72av., 70-111 Szczecin, Poland

autor

Gutowska I.

autor

Marchlewicz M.

autor

Nocen I.

autor

Czuprynska K.

autor

Olszewska M.

autor

Skotnicka E.

autor

Jach M.

autor

Wiszniewska B.

autor

Chlubek D.

Bibliografia

• 1. GRANDJEAN P., OLSEN N.B. Lead. In: Hazardous Metals in Human Toxicology, Part B.; A. Veromysse (eds.), Elsevier: Amsterdam, 1984.
• 2. HU H., RABINOWITZ M., SMITH D. Bone lead as biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ. Health Perspect. 106, 1, 1998.
• 3. O’FLAHERTY E.J. A physiologically based kinetic model for lead in children and adults. Environ.Health Perspect. 106 (6), 1495, 2000.
• 4. GWIAZDA R., CAMPBELL C., SMITH D. A non-invasive isotopic approaches to estimate the bone lead in children: implications for assessing the efficacy of lead abatement. Environ. Health Perspect. 113, 104, 2005.
• 5. FOWLER B.A. Biological roles of high affinity metal-binding proteins in mediating cell injury. Comm. Toxicol. 3, 27, 1989.
• 6. SIMONS T.J.B. Lead transport and binding by human erythrocytes in vitro. Pfugers Arch. 423, 307, 1993.
• 7. KOSTIAL K., BLANUSA M., PIASEK M., RESTEK-SAMARZIJA N., JONEM M.M., SIGM P.K. Combined chelation therapy in reducing lead concentrations in suckling rats. J. App. Toxicol. 19, 143, 1999.
• 8. LISIEWICZ J., MOSZCZYŃSKI P. Industrial Hematology. PZWL: Warsaw, 1999. [In Polish]
• 9. CANFIELD R.L., HENDERSON C.R., CORY-SLECHTA D.A., COX C., JUSKO T.A., LANPHEAR B.P. Intellectual impairment in children with blood concentrations below 10 µg per decilitre. N. Eng. J. Med. 348, 1517, 2003.
• 10. DIETRICH K.N., RIS M.D., SUCCOP P.A., BERGER O.G., BORNSCHEIN R.L. Early exposure to lead and juvenile delinquency. Neurotoxicol. Teratol. 32, 511, 2001.
• 11. NEEDLEMAN H.L., FARLAND C., NESS R.B., FIENBERG S.E., TOBIN M.J. Bone lead levels in adjudicated delinquents: a case-control study. Neurotoxicol. Teratol. 24, 711, 2002.
• 12. MARCHLEWICZ M., WISZNIEWSKA B., GONET B., BARANOWSKA-BOSIACKA I., SAFRANOW K., KOLASA A., GŁĄBOWSKI W., KURZAWA R., JAKUBOWSKA K., RAĆ M. Increased lipid peroxidation and ascorbic acid utilization in testis and epididymis of rats chronically exposed to lead. BioMetals 20, 13, 2006.
• 13. PAL S., CHATTERJEE A.K. Possible beneficial effects of melatonin supplementation on arsenic-induced oxidative stress in Wistar rats. Drug. Chem. Toxicol. 29, 423, 2006.
• 14. REITER R.J., TAN D.X., QI W., MANCHESTER L.C., KARBOWNIK M., CALVI J.R. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol. Signals Recept. 9, 160, 2000.
• 15. JOU M.J., PENG T.I., REITER R.J., JOU S.B., WU H.Y.,WEN S.T. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stressinduced apoptosis of rat brain astrocytes. J. Pineal. Res. 37, 55, 2004.
• 16. KARBOWNIK M., GITTO E., LEWINSKI A., REITER R.J. Introduction of lipid peroxidation in hamster organs by the carcinogen cadmium: amelioration by melatonin. Cell Biol. Toxicol. 17, 33, 2001.
• 17. REITER R.J., TAN D.X., MANCCHESTER L.C, CALVO J.R. Handbook of antioxidants. Marcel Dekker. New York, pp. 565-613, 2002.
• 18. SMIRNOV A.N. Nuclear melatonin receptors. Biochemistry (Mosc) 1, 19, 2001.
• 19. ANTOLIN I., RODRIQUES C., SAINZ R.M., MAYO J.C., URIA H., KOTLER M.L., RODRIQUES-COLUNGA M.J., TOLIVIA D., MENENDEZ-PELAEZ A. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J. 10, 882, 1996.
• 20. SRINIVASAN V. Melatonin oxidative stress and neurodegenerative diseases. Indian J. Exp. Biol. 40, 668, 2002.
• 21. SURESH C., DENNIS A.O., HEINZ J., VEMURI M.C., CHETTY C.S. Melatonin protection against lead-induced changes in human neuroblastoma cell cultures. Int J Toxicol. 25, 459, 2006.
• 22. EL-SOKKARY G.H., ABDEL-RAHMAN G.H., KAMEL E.S. Melatonin protects against lead-induced hepatic and renal toxicity in male rats. Toxicology. 213, 25, 2005.
• 23. OTHMAN A.I., AL SHARAWY S., EL-MISSIRY M.A. Role of melatonin in ameliorating lead induced haematotoxicity. Pharmacol Res. 50, 301, 2004.
• 24. FLORA S.J., PANDE M., KANNAN G.M., MEHTA A. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats. Cell. Mol. Biol. 50, 543, 2004.
• 25. EL-MISSIRY M.A. Prophylactic effect of melatonin on lead-induced inhibition of heme biosynthesis and deterioration of antioxidant systems in male rats. J. Biochem. Mol. Toxicol. 14, 57, 2000.
• 26. KIM Y.O., PYO M.Y., KIM J.H. Influence of melatonin on immunotoxicity of lead. Int. J Immunopharmacol. 22, 821, 2000.
• 27. WESTRLUND-HELMERSON U. Determination of lead and cadmium in blood by modification of the Hassel method. At. Abs. News 9, 133, 1978.
• 28. CDC (Centers for Disease Control). Preventing lead poisoning in young children. United States Department of Health and Human Services: Department of Health and Human Services: Atlanta, 1991.
• 29. SEŃCZUK W. Toxicology. PZWL: Warsaw, pp 490-427, 1994. [In Polish]
• 30. WHO. Environmental Health Criteria 165. Inorganic lead. Geneva, 1995.
• 31. CDC (Centres for Disease Control). United States Department of Health and Human Services: Atlanta, 2004. http:// www.cdc.gov/nceh/lead/ACCLPP/meetingMinutes/lessThan10MtgMAR04.pdf
• 32. LIDSKY T.I., SCHNEIDER J.S. Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain 126, 5, 2003.
• 33. KARBOWNIK M., GITTO E., LEWINSKI A., REITER R.J. Introduction of lipid peroxidation in hamster organs by the carcinogen cadmium: amelioration by melatonin. Cell Biol. Toxicol. 17, 33, 2001.
• 34. REITER R.J., TAN D.X., QI W., MANCHESTER L.C., KARBOWNIK M., CALVI J.R., Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol. Signals Recept. 9, 160, 2000.
• 35. DIETRICH K.N., WARE J.H., SALGANIK M., RADCLIFFE J., ROGAN W.J., RHOADS G.G., FAY M.E., DAVOLI C.T., DENCKLA M.B., BORNSCHEIN R.L., SCHWARZ D., DOCKERY D.W., ADUBATO S., JONES R.L. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry. Pediatrics 114,19, 2004.
• 36. CANFIELD R.L., GENDLE M.H., CORY-SLECHTA.D.A. Impaired neuropsychological functioning in lead-exposed children. Dev. Neuropsychol. 26, 513, 2004.
• 37. EL-SOKKARY G.H., KAMEL E.S., REITER R. Prophylactic effect of melatonin in reducing lead-induced neurotoxicity in the rat. Cell. Moll. Biol. Lett. 8, 461, 2003.
• 38. CHWEŁATIUK E., WŁOSTOWSKI T., KRASOWSKA A., BONDA E. The effect of orally administred melatonin on tissue accumulation and toxicity of cadmium in mice. J. Trace. Elem. Biol. Med. 19, 259, 2006.
• 39. LIMSON J., NYOKONG T., DAYA S. The interaction of melatonin and its precursors with aluminum, cadmium, copper, iron, lead and zinc: an adsorptive voltammetric study. J. Pineal. Res. 24, 15, 1998.
• 40. REITER R.J., TAN D.X., SAINZ RM, MAYO JC, LOPEZBURILLO S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J. Pharm. Pharmacol. 54, 1299, 2002.
• 41. BODAK E., KOŁACZ R., DOBRZAŃSKI Z. Heavy metals – the conditions of exposure and the defensive mechanisms in animals. Med. Wet. 52, 619, 1996. [In Polish]
• 42. AUNGST B.J., FUNG H.L. Kinetic characterization of in vitro lead transport across the rat small intestine. Toxicol. Appl. Pharmacol. 61, 39, 1981.
• 43. VARNAI V.M., SARIC M., MOKROVIC G., PIASEK M., BLANUSA M., BULJAN C.J., MATEK S.M., KOSTIAL K. The effect of dietary supplementation with calcium salts on skeletal calcium in suckling rats. Arh. Hig. Toksikol. 54, 119, 2003.
• 44. SILDERBERG E.K. Lead in bone: implications for toxicology during pregnancy and lactation. Environ. Health Perspect. 91, 63, 1991.
• 45. RABINOWITZ B.M. Toxicokinetics of bone lead. Environ. Health Perspect. 91, 33, 1991.
• 46. POUNDS J.G., Long G.J. Cellular and molecular toxicity of lead in bone. Environ. Health Perspect. 91, 17, 1991.
• 47. KOO WW., SUCCOP P.A., BORNSCHEIN R.L., KRUGWISPE SK., STEINCHEN J.J., TSANG R.C., BERGER O.G. Serum vitamin D metabolites and bone mineralization in young children with chronic low to moderate lead exposure. Pediatrics. 87, 680, 1991.
• 48. HEARD M., CHAMBERLAIN A. uptake of lead by human skeleton and comparative metabolism of lead and alkaline earth elements. Health Phys.47, 857, 1984.
• 49. DURLACH J. Magnesium in clinical practice. PZWL, Warsaw, 1991.